Home NDC 27854-160 Flanax
Product NDC 27854-160
11-digit product format 278540160
Labeler code 27854
Product ID 27854-160_15256b57-2263-447e-9a11-f3f8f7edd6c3
Type HUMAN OTC DRUG
Nonproprietary name Naproxen Sodium
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Belmora LLC
Application ANDA204872
Marketing category ANDA
Marketing start 2018-01-15
Substance NAPROXEN SODIUM
Active strength 220 mg/1
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 11 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A204872-001 NAPROXEN SODIUM NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 c2088c7a36db…2026-09-14 22:38:34 2026-08 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A204872-001 NAPROXEN SODIUM EQ 200MG BASE TABLET / ORAL 2017-01-23 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A204872-001 NAPROXEN SODIUM EQ 200MG BASE TABLET / ORAL 2017-01-23 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A204872-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2017-01-23 3a93d1ddd44b…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Flanax
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NAPROXEN SODIUM 220 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9TN87S3A3C Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 849574 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 27854-160-00 Flanax 100 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 100 14 27854-160-00 Flanax 1 in 1 CARTON TABLET, FILM COATED 1 14 27854-160-01 Flanax 1 in 1 CARTON TABLET, FILM COATED 1 14 27854-160-01 Flanax 10 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 10 14 27854-160-24 Flanax 24 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 24 14 27854-160-24 Flanax 1 in 1 CARTON TABLET, FILM COATED 1 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 27854-160 FLANAX (NAPROXEN SODIUM) TABLET, FILM COATED [BELMORA LLC] 12 Current NDC, Legacy NDC, 6 package rows 20240825_2c099d45-f03a-4161-a6af-8fe5965f2748.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 24 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 27854-160-00 27854016000 1 BOTTLE, PLASTIC in 1 CARTON (27854-160-00) > 100 TABLET, COATED in 1 BOTTLE, PLASTIC 2018-01-15 0000-00-00 No No Current 27854-160-01 27854016001 1 BOTTLE, PLASTIC in 1 CARTON (27854-160-01) / 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 2018-01-15 0000-00-00 No No Current 27854-160-24 27854016024 1 BOTTLE, PLASTIC in 1 CARTON (27854-160-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 2018-01-15 0000-00-00 No No Current